Antengene Announces First Patient Dosed in the Phase I STAMINA-001 Study of ATG-037 for the Treatment of Patients with Locally Advanced or Metastatic Solid Tumors 5 min read Health & Fitness Beat Antengene Announces First Patient Dosed in the Phase I STAMINA-001 Study of ATG-037 for the Treatment of Patients with Locally Advanced or Metastatic Solid Tumors GetHealthAccess | Antengene Announces First Patient Dosed in the Phase I STAMINA-001 Study of ATG-037 for the...Read More
